All In Biotech

Drug Trial Radar · NCT02101359

Efficacy and Safety Assessment of Intracameral Injection of T2380 in Cataract Surgery

Efficacy and Safety Assessment of Intracameral Injection of T2380 in Cataract Surgery Versus Reference Group (Topical Mydriatics and Anaesthetic)

Last checked: Nov 20, 2026Latest source record: Nov 14, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 609 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

609

Actual

Start

Jun 2011

Primary completion

Jan 2013

Study completion May 2013

Sponsor

Lead sponsor
Laboratoires TheaIndustry
Sponsor type
Industry
First posted
Apr 2, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 40 years, up to 88 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine the efficacy and safety assessment of T2380 for mydriasis and anaesthesia in phacoemulsification cataract surgery versus reference group (topical mydriatics and anaesthetic) 2X246 patients.

Conditions

  • Cataract

Interventions

  • T2380Drug

    200 microlitres of T2380 will be administrated intracamerally

  • MydriaticsDrug

    3 drops of tropicamide and phenylephrine were instilled 30 minutes before surgery. The second and the third instillation of both phenylephrine and tropicamide will be realised respectively within 20 and 10 minutes before surgery.

  • TetracaineDrug

    Two drops of tetracaine were instilled in the eye to be operated 5 minutes and 1 minute before surgery

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Primary Efficacy Variable is Response Based on the Realisation of the Capsulorhexis Without Use of Any Additive Mydriatic Treatment.Time frame: Day 0

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Laboratoires Thea

    Clermont-Ferrand, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.